Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo‐Controlled Clinical Trial

OBJECTIVE: To examine the results of raloxifene for prevention of periprosthetic bone loss around the femoral stem in patients undergoing total hip arthroplasty (THA). METHODS: Between January 2015 and May 2017, 240 female patients between 55 and 80 years underwent primary THA and were randomly allo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Long, Zhang, Yao‐yao, Yang, Na, Qian, Huan‐juan, Zhang, Ling‐kun, Tan, Ming‐sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454213/
https://www.ncbi.nlm.nih.gov/pubmed/32686337
http://dx.doi.org/10.1111/os.12696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454213/
https://www.ncbi.nlm.nih.gov/pubmed/32686337
http://dx.doi.org/10.1111/os.12696

Ejemplares similares